Venture-Backed Startups

Audio branding studio that creates sonic identities and custom scoring for global brands. Part of Universal Music Group, the company develops strategic audio systems and original compositions to help brands establish distinctive sensory connections with audiences.

1 investor

Eliaz Therapeutics develops XGal-3, an investigational therapeutic apheresis device that uses an antibody-based resin to remove the protein Galectin-3 from the bloodstream. It targets Galectin-3 as a driver of sepsis, cancer, heart disease, fibrosis, and kidney disease, and is in the preclinical and first-in-human study stage.

0 investors

Elice is an AI full-stack company providing AI infrastructure, cloud services, and industry-specific solutions, including modular AI data centers ("Elice AI PMDC"), the learning and practice platform "Elice LXP," the "Helpy" industry-specialized AI model series, and MLOps pipelines. Its products serve education and enterprise use cases, including generative AI talent cultivation and domain-specialized model development.

1 investor

Elicio Therapeutics is a biopharmaceutical company focused on developing therapeutic treatments.

1 investor

Elicit is an AI-powered research assistant that helps users discover, analyze, and synthesize scientific literature and research findings. The platform serves researchers, academics, and professionals in life sciences, healthcare, and related fields who need to conduct evidence-based analysis at scale.

5 investors

Elicit Plant develops agricultural solutions that trigger plants' natural defenses to help field crops resist water stress and adapt to climate change. It targets the farming and food production sector with technology aimed at building more climate-resilient crops.

2 investors

Elidah develops an FDA-cleared external neuromuscular therapy platform for treating urinary incontinence in women and men, offered through direct-to-consumer and clinical care channels including telehealth and Medicare coverage.

1 investor

1 investor

ELIGARD is a GnRH agonist medication in injectable form used to treat prostate cancer by reducing testosterone production. The product offers multiple dosing schedules for patients with metastatic castration-sensitive prostate cancer.

1 investor

Eligible provides a configurable customer engagement platform that uses lender data to deliver real-time, multi-channel journeys (email, SMS, QR, app) around key mortgage moments such as SVR, retention, switching, and maturity. It serves mortgage lenders, aiming to improve retention, reduce costs, and meet compliance outcomes.

1 investor

Eligible provides APIs that healthcare businesses use to manage insurance billing and claims processing. The platform serves both early-stage healthcare startups and established healthcare organizations.

2 investors

EligoChem is a drug discovery company staffed by directors with expertise in medicinal and computational chemistry, biology assay development, and screening.

1 investor

0 investors

Eliksa Therapeutics develops innovative treatments for rare diseases with unmet medical needs.

2 investors

Elin is a mobile app marketed as a "cognitive antivirus" that protects users' attention and mental well-being from addictive social media algorithms, offering tools like a digital resilience course, psychological tests, mood tracking, social feed scoring, and a non-toxic AI support chat. It targets individuals — including teenagers and their parents — seeking to reduce doomscrolling, FOMO, and digital overload.

1 investor

Elina is an AI-powered assistant designed specifically for early childhood educators that helps with lesson planning, documentation, child profiles, and activity suggestions tailored to individual classrooms and children's needs.

1 investor

Elio develops adaptive sensors that enable AI systems to dynamically select information at variable resolutions and dimensions, giving machine intelligence direct perception capabilities for physical world applications.

3 investors

0 investors

Elio provides sustainability-by-design decision support software for R&D scientists, process engineers, and product managers. The tool uses life-cycle assessment (LCA) data, material composition prediction, and emissions calculations to help evaluate the environmental impact of products such as packaging and materials.

1 investor

5 investors

0 investors

Clinical-stage biotech developing next-generation polyene antifungals for life-threatening invasive fungal infections.

2 investors

Elior Group operates a contract catering and multiservice business serving collective feeding operations across 11 countries, with a focus on sustainability, healthy nutrition, and environmental responsibility. The company manages over 3.2 million meals daily and emphasizes reducing carbon emissions, food waste, and promoting circular economy practices in its supply chain.

1 investor

Implant-free, minimally invasive glaucoma surgery (MIGS) creating microscopic channels in the eye to lower intraocular pressure.

1 investor